The global immuno-oncology assays market is estimated to be valued at US$ 3,718.5 million in 2021 and is expected to exhibit a CAGR of 10.7% over the forecast period 2022-2028, as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
Immuno-oncology assays are vital tools used in cancer research and treatment. These assays help in screening and monitoring cancer patients, as they provide valuable insights into the immune response to tumors. ... Read more
